ArticleScientific reports2019

Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy.

Ryoichi Bessho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.